Back to top

Myriad Genetics Inc: (NSDQ: MYGN)

(U.S: NSDQ) As of Jul 30, 2014 03:59 PM ET

 Add to portfolio

 ZacksTrade Now

$36.72 USD

36.72

-0.33 (-0.89%)

Volume: 407,905

Zacks Rank : 3-Hold [?]     3    

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Balance Sheet

Fiscal Year End for MYRIAD GENETICS falls in the month of June.

All items in Millions except Per Share data.

6/30/2014 6/30/2013 6/30/2012 6/30/2011 6/30/2010
Assets          
Cash & Equivalents NA 372 341 346 403
Receivables NA 98 63 51 48
Notes Receivable NA 0 0 0 0
Inventories NA 5 12 6 0
Other Current Assets NA 9 7 15 23
Total Current Assets NA 484 422 418 474
Net Property & Equipment NA 28 24 23 23
Investments & Advances NA 159 114 71 85
Other Non-Current Assets NA 22 19 0 0
Deferred Charges NA 29 31 26 9
Intangibles NA 70 73 73 0
Deposits & Other Assets NA 13 8 0 2
Total Assets NA 804 691 611 594
Liabilities & Shareholders Equity 6/30/2014 6/30/2013 6/30/2012 6/30/2011 6/30/2010
Notes Payable NA 0 0 0 0
Accounts Payable NA 18 10 11 9
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 44 33 22 19
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 2 2 1 0
Total Current Liabilities NA 65 45 34 27
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 11 10 10 9
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 75 55 44 36
Shareholders Equity 6/30/2014 6/30/2013 6/30/2012 6/30/2011 6/30/2010
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 1 1 1 1
Capital Surplus NA 697 648 604 567
Retained Earnings NA 31 -13 -39 -10
Other Equity NA -0 -0 0 0
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 729 636 567 558
Total Liabilities & Shareholder's Equity NA 804 691 611 594
Total Common Equity 0 729 636 567 558
Shares Outstanding 74.80 79.60 84.80 85.70 97.70
Book Value Per Share 0.00 9.15 7.50 6.61 5.71

Fiscal Year End for MYRIAD GENETICS falls in the month of June.

All items in Millions except Per Share data.

6/30/2014 3/31/2014 12/31/2013 9/30/2013 6/30/2013
Assets          
Cash & Equivalents NA 212 354 357 372
Receivables NA 86 88 88 98
Notes Receivable NA 0 0 0 0
Inventories NA 19 0 0 5
Other Current Assets NA 21 13 14 9
Total Current Assets NA 338 455 459 484
Net Property & Equipment NA 33 31 31 28
Investments & Advances NA 66 135 159 159
Other Non-Current Assets NA 0 23 22 22
Deferred Charges NA 0 30 28 29
Intangibles NA 375 70 70 70
Deposits & Other Assets NA 5 13 13 13
Total Assets NA 816 757 782 804
Liabilities & Shareholders Equity 6/30/2014 3/31/2014 12/31/2013 9/30/2013 6/30/2013
Notes Payable NA 0 0 0 0
Accounts Payable NA 19 18 19 18
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 51 46 59 44
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 2 4 1 2
Total Current Liabilities NA 72 67 79 65
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 8 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 13 12 11
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 94 81 91 75
Shareholders Equity 6/30/2014 3/31/2014 12/31/2013 9/30/2013 6/30/2013
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 1 1 1 1
Capital Surplus NA 703 663 675 697
Retained Earnings NA 19 12 14 31
Other Equity NA -0 1 0 -0
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 722 676 690 729
Total Liabilities & Shareholder's Equity NA 816 757 782 804
Total Common Equity 0 722 676 690 729
Shares Outstanding 74.80 72.90 74.70 80.40 79.60
Book Value Per Share 0.00 9.91 9.05 8.59 9.15